Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (6): 94-102.doi: 10.6040/j.issn.1671-7554.0.2021.0231

Previous Articles     Next Articles

Construction of circRNA-mediated ceRNA network and prognostic assessment model for bladder cancer

MI Qi, SHI Shuang, LI Juan, LI Peilong, DU Lutao, WANG Chuanxin   

  1. Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Published:2021-06-10

PDF (PC)

488

Abstract: Objective To identify the differentially expressed circular RNAs(circRNAs)and construct a circRNAs-mediated ceRNA network and a prognostic assessment model. Methods Data were downloaded from Gene Expression Omnibus(GEO)and The Cancer Genome Atlas(TCGA)database. Differential expressed analysis was performed to explore the differentially expressed RNAs in bladder cancer tissues with the standard of |log2 fold change(log2FC)|>1, P<0.05. Based on multiple detabases, such as TCGA and CircInteractome, the circRNA-miRNA-mRNA ceRNA network was constructed, and functional enrichment analysis of mRNAs was conducted. Subsequently, the relationship of mRNAs in ceRNA network was analyzed through the String database. The mRNAs related to prognosis were screened with univariate Cox regression model, and a prognostic assessment model was constructed. A ROC curve was drawn with “time ROC” package to evaluate the effectiveness of the model. Results Differential expressed analysis screened out 4 circRNAs, including hsa_circ_0102787, hsa_circ_0103114, hsa_circ_0102402 and hsa_circ_0104387. A ceRNA network was constructed, which contained 4 circRNAs, 23 miRNAs and 86 mRNAs. Functional enrichment analysis showed those mRNAs participated in several cancer-related pathways. The interaction between mRNAs in the ceRNA network was visualized by PPI network. Survival analysis revealed that 6 mRNAs were related to the prognosis of bladder cancer. Then, a prognostic assessment model was constructed based on “the risk score=(-0.356 9)×ABRACL+(-0.264 4)×MAP3K8.” Kaplan Meier analysis showed patients with high risks had a poor prognosis(P<0.001), and the AUC of the five-year overall survival rate was 0.744. Conclusion This study identififed 4 differentially expressed circRNAs, and constructed a circRNA-miRNA-mRNA network and a prognostic assessment model, which provides a new insight for the exploration of the occurrence and development of bladder cancer.

Key words: Bladder cancer, circRNAs, ceRNA, Prognosis, Cox regression model

CLC Number: 

  • R737.14
[1] Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends [J]. Eur Urol, 2017, 71(1): 96-108.
[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[3] Robertson AG, Kim J, Al-Ahmadie H, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer [J]. Cell, 2017, 171(3): 540-556.
[4] Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder cancer [J]. Lancet, 2016, 388(10061): 2796-2810.
[5] Witjes JA, Lebret T, Comperat EM, et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer [J]. Eur Urol, 2017, 71(3): 462-475.
[6] Dreicer R. Chemotherapy for advanced urothelial cancer: end of the beginning? [J]. Lancet Oncol, 2017, 18(5): 567-569.
[7] Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 years of maintenance bacillus calmette-guerin [J]. Eur Urol, 2016, 69(1): 60-69.
[8] Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs [J]. Nat Biotechnol, 2014, 32(5): 453-461.
[9] Liu YC, Li JR, Sun CH, et al. CircNet: a database of circular RNAs derived from transcriptome sequencing data [J]. Nucleic Acids Res, 2016, 44(D1): D209-215.
[10] Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495(7441): 333-338.
[11] Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition [J]. Nature, 2014, 505(7483): 344-352.
[12] Su Y, Feng W, Shi J, et al. Correction to: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway [J]. Mol Cancer, 2021, 20(1): 1. doi: 10.1186/s12943-019-1129-5.
[13] Su H, Tao T, Yang Z, et al. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression [J]. Mol Cancer, 2019, 18(1): 27. doi: 10.1186/s12943-019-0951-0.
[14] Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer [J]. Mol Cancer, 2017, 16(1): 94. doi: 10.1186/s12943-017-0663-2.
[15] Wang Z, Jensen MA, Zenklusen JC. A practical guide to the cancer genome atlas(TCGA)[J]. Methods in molecular biology(Clifton, NJ), 2016, 1418: 111-141. doi: 10.1007/978-1-4939-3578-9_6.
[16] Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies [J]. Nucleic acids research, 2015, 43(7): e47. doi: 10.1093/nar/gkv007.
[17] Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data [J]. Bioinformatics, 2010, 26(1): 139-140.
[18] Dudekula DB, Panda AC, Grammatikakis I, et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs [J]. RNA Biol, 2016, 13(1): 34-42.
[19] Jiang J, Bi Y, Liu XP, et al. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer [J]. J Cell Mol Med, 2020, 24(9): 5375-5386.
[20] Otasek D, Morris JH, Boucas J, et al. Cytoscape Automation: empowering workflow-based network analysis [J]. Genome Biol, 2019, 20(1): 185. doi: 10.1186/s13059-019-1758-4.
[21] Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs [J]. Nucleic Acids Res, 2017, 45(D1): D353-D361.
[22] Gene OC. Gene ontology consortium: going forward [J]. Nucleic Acids Res, 2015, 43(Database issue): D1049-1056.
[23] Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res, 2019, 47(D1): D607-D613.
[24] Weng W, Wei Q, Toden S, et al. Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer [J]. Clin Cancer Res, 2017, 23(14): 3918-3928.
[25] Cheng Z, Yu C, Cui S, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1 [J]. Nat Commun, 2019, 10(1): 3200. doi: 10.1038/s41467-019-11162-4.
[26] Zeng Z, Zhou W, Duan L, et al. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway[J]. J Cell Physiol, 2019, 234(4): 3887-3896.
[27] 史爽, 李娟, 米琦, 等. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报(医学版), 2020, 58(7): 47-52. SHI Shuang, LI Juan, MI Qi, et al. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University(Health Sciences), 2020, 58(7): 47-52.
[28] Chen Y, Xu T, Xie F, et al. Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer [J]. Oncol Rep, 2021, 45(1): 191-201.
[29] Vougioukalaki M, Kanellis DC, Gkouskou K, et al. Tpl2 kinase signal transduction in inflammation and cancer[J]. Cancer Letters, 2011, 304(2): 80-89.
[1] LI Ziqi, WEI Yanruoxue, LIU Xiaohan, LIU Chuncheng, ZHAO Ran, LIU Yukun. The functional role and clinical significance of lncRNA HEATR3-AS1 in colorectal cancer tumorigenesis and progression [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 108-115.
[2] CHEN Yingying, WANG Lu, HU Xifeng, ZHU Gaopei, XUE Fuzhong. A Bayesian network-based risk prediction study of stroke in patients with type 2 diabetes mellitus [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 94-102.
[3] LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74.
[4] WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54.
[5] JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99.
[6] DU Xue, LI Chunxia, LIU Yunxia, ZHANG Tao. Dynamic prediction model for the colorectal cancer patients prognosis based on MFPC-Cox [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 101-110.
[7] YANG Weifang, XU Hong, LIU Yuantao, ZHAO Huichen. Mechanism of thyroid-stimulating immunoglobulin in Graves disease recurrence and clinical significance [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 116-121.
[8] LIU Wenzhao, ZHANG Yuan, MA Xiangping, WEI Fengtao, BU Peili. Correlation between the pre-endothelial activation and stress index and the mortality risk of patients with heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 27-35.
[9] CHEN Wenliang, WANG Huanhuan, HAO Jinjin, GONG Rui, ZHAO Qiang, ZHANG Fei, GAO Lei, DONG Jingxun. The role of lncRNA PVT1 in prognostic assessment and malignant progression of gastric cancer: a study based on nomogram model and functional cellular experiments [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 61-71.
[10] GUO Shuhua, FAN Yang, TIAN Feng, WANG Chuanxin, DU Lutao, LI Peilong, GUO Xing, XU Shuo. Role of microfibril-associated protein 3 in regulating mesenchymal transition of glioma stem cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 9-16.
[11] WEI Yanruoxue, LI Ziqi, LIU Chuncheng, LIU Xiaohan, ZHAO Ran, LIU Yukun. Intratumor heterogeneity of SP1 expression in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 89-94.
[12] LIU Chuncheng, LIU Xiaohan, WEI Yanruoxue, LI Ziqi, LIU Yukun, ZHAO Ran. Subcellular localization pattern of bromodomain containing 9 in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 24-30.
[13] YANG Xueyan, WU Yinping, LYU Li, ZHAO Zehua, MA Hangyu, LI Fengcai, WANG Kai, FAN Yuchen. Diagnostic value of dynamic changes of monocyte-to-lymphocyte ratio in acute-on-chronic hepatitis B liver failure [J]. Journal of Shandong University (Health Sciences), 2024, 62(3): 61-69.
[14] DIAO Yujie, LIN Lin, LI Wenxuan, WANG Zhouyang, JIANG Bei, HU Yingying, LIU Guangyi. Neutrophil-to-platelet ratio predicts adverse renal outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis and its synergistic multifactor optimization model [J]. Journal of Shandong University (Health Sciences), 2024, 62(2): 60-68.
[15] LIU Yan, LENG Shanshan, XIA Xiaona, DONG Hao, HUANG Chencui, MENG Xiangshui. Functional outcomes of 376 patients with supratentorial spontaneous intracerebral hemorrhage based on radiomic parameters [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 59-67.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd